Issue 10, 2015

RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies

Abstract

Malignant primary brain tumors are aggressive cancerous cells that invade the surrounding tissues of the central nervous system. The current treatment options for malignant brain tumors are limited due to the inability to cross the blood–brain barrier. The advancements in current research has identified and characterized certain molecular markers that are essential for tumor survival, progression, metastasis and angiogenesis. These molecular markers have served as therapeutic targets for the RNAi based therapies, which enable site-specific silencing of the gene responsible for tumor proliferation. However, to bring about therapeutic success, an efficient delivery carrier that can cross the blood–brain barrier and reach the targeted site is essential. The current review focuses on the potential of targeted, non-viral and viral particles containing RNAi therapeutic molecules as delivery strategies specifically for brain tumors.

Graphical abstract: RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies

Article information

Article type
Review Article
Submitted
20 апр. 2015
Accepted
23 јун. 2015
First published
25 јун. 2015

Mol. BioSyst., 2015,11, 2635-2657

Author version available

RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies

M. Malhotra, A. Toulouse, B. M. D. C. Godinho, D. J. Mc Carthy, J. F. Cryan and C. M. O'Driscoll, Mol. BioSyst., 2015, 11, 2635 DOI: 10.1039/C5MB00278H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements